1. National Comprehensive Cancer Network: Clinical practice guidelines in oncology 2004: Antiemesis. http://www.nccn.org/physician_gls/f_guidelines.html. Accessed September 2004.
2. Multinational Association of Supportive Care in Cancer (MASCC) Antiemetic Guideline Committee: Antiemetic guidelines from the consensus conference on antiemetic therapy. Perugia International Cancer Conference VII, 29-31 March 2004, Perugia, Italy.
3. An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting
4. EmendR (aprepitant). Prescribing information. Merck & Co., Inc., Whitehouse Station, New Jersey, 2003.